DIM: hope for ovarian cancer
Ovarian cancer is the fifth most common cancer affecting women in the UK, and 6,500 women are diagnosed every year. Cisplatin is commonly used to treat ovarian… Read more »
Claire Barnard
Claire studied at the University of Sheffield, completing a PhD investigating mast cell ion channels as targets for asthma therapy. She joined BioMed Central in 2011, and is Deputy Editor for BMC Medicine.
Latest posts by Claire Barnard (see all)
- Open medicine digest: smoking cessation, antimalarials, prostate cancer genomics, and more - 30th November 2015
- What’s next for prostate cancer screening? - 27th November 2015
- Cancer prevention, genome-driven treatment, and mobilizing the immune system: highlights from NCRI 2015 - 13th November 2015